Advantages and disadvantages of PET and SPECT in a busy clinical practice
- 2k Downloads
The continued high utilization of rest-stress single-photon emission computed tomographic (SPECT) myocardial perfusion imaging (MPI) is supported by its known clinical benefits, established reimbursement, and wide availability of cameras and radiopharmaceuticals. However, traditional rest-stress SPECT protocols tend to be lengthy and inefficient, and the prevalence of equivocal studies continues to be a problem. The use of stress-only SPECT protocols in selected patients, and a new generation of ultrafast SPECT cameras have led to improved image quality, reduced dosimetry and shorter, more efficient MPI protocols. The utilization of positron emission tomographic (PET) MPI has been accelerated by the availability of radiopharmaceuticals that can be generated on-site, and by the availability of more PET cameras. Emerging evidence consistently demonstrates that PET provides improved image quality, greater interpretive certainty, higher diagnostic accuracy, lower patient dosimetry, and shorter imaging protocols as compared to SPECT. Importantly, PET imaging allows assessment of left ventricular function at peak-stress, and evaluation of microvascular function through the measurement of absolute myocardial blood flow at rest and at peak-stress. Wider utilization of PET MPI is hindered by a high cost of entry, high on-going costs, and an immature reimbursement structure.
Key WordsSPECT PET Myocardial perfusion imaging
Dr Bateman reported receiving grant support from Bracco Diagnostics, Philips Healthcare, GE Healthcare, Lantheus Medical Imaging, Astellas Pharmaceuticals, CellPoint, and SpectrumDynamics. Dr Bateman reported receiving royalties from ExSPECT II, and ImagenPro/MD/Q. Dr Bateman reported stock ownership in CVIT. Dr Bateman reported to be part of the advisory board for Bracco Diagnostics, Lantheus Medical Imaging, Spectrum Dynamics, Astellas Pharmaceuticals, and GE Healthcare.
- 1.Klocke FJ, Baird MG, Lorell BH, Bateman TM, Messer JV, Berman DS, et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). Circulation 2003;108:1404-18.PubMedCrossRefGoogle Scholar
- 2.Des Prez RD, Dahlberg ST, Einstein AJ, et al. ASNC Clinical Update. Stress-Only Myocardial Perfusion Imaging, 2009 http://www.asnc.org/imageuploads/ClinicalUpdateStressOnlyMPI2009.pdf. Accessed Jan 5, 2011.
- 13.Lertsburapa K, Ahlberg AW, Bateman TM, Katten D, Volker L, Cullom SJ, et al. Independent and incremental prognostic value of left ventricular ejection fraction determined by stress gated rubidium-82 PET imaging in patients with known or suspected coronary artery disease. J Nucl Cardiol 2008;15:745-53.PubMedGoogle Scholar